Skip to main content
. 2023 Oct 1;49(10):425–432. doi: 10.14745/ccdr.v49i10a03

Table 1. Input parameters.

Variable Estimate Source, year publication (reference)
Symptom classes Probabilities (%)
Non-overlapping Overlapping
Chronic fatigue 42.99 72.1 Health Infobase, 2022 ((13))
Psychiatric conditions 14.43 24.2
Cognitive conditions 19.62 32.9
Respiratory disease 22.96 38.5
Likelihood of becoming a PCC case (by vaccination status)
Unvaccinated 41.8 N/A Azzolini et al., 2022 ((14))
1st dose 30.0
2nd dose 17.4
3rd dose 16.0
Health related quality of life decrements
Chronic fatigue 0.36 Versteegh et al., 2016 ((15))
Psychiatric conditions 0.21 Steensma et al., 2016 ((16))
Cognitive conditions 0.12 Song et al., 2022 ((17))
Respiratory disease 0.37 Van Wilder et al., 2019 ((18))
Costs (Canadian dollars)
Chronic fatigue 12,753 Jason et al., 2008 ((19))
Psychiatric conditions 4,123 Chiu et al., 2017 ((20))
Cognitive conditions 9,939 Zhu et al., 2013 ((21))
Respiratory disease 10,641 Bonafede et al., 2011 ((22))
Other variables
Number of patients with at least one PCC symptom Low: 0.74 million
Medium: 2.02 million
High: 2.88 million
Health Infobase, 2023 ((23))
Health Infobase, 2023 ((24))
Statistics Canada, 2023 ((25))

Abbreviations: N/A, not applicable; PCC, post-COVID-19 condition (COVID-19, coronavirus disease 2019)